Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,810 | -114,347 | -61,335 | -55,978 | -23,972 |
| Depreciation Amortization | 12,804 | 48,804 | 36,513 | 23,509 | 11,450 |
| Income taxes - deferred | -43 | -9,921 | -10,610 | 143 | 712 |
| Accounts receivable | -11,279 | -4,227 | -12,451 | 4,089 | -989 |
| Other Working Capital | -31,784 | 33,059 | 6,233 | -662 | -6,877 |
| Other Operating Activity | 38,083 | 64,241 | 47,273 | 20,308 | 12,505 |
| Operating Cash Flow | $-32,029 | $17,609 | $5,623 | $-8,591 | $-7,171 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,761 | -144,331 | -111,358 | -105,424 | 37,475 |
| PPE Investments | -11,826 | -44,571 | -30,676 | -15,663 | -6,179 |
| Net Acquisitions | -9,875 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -1,743 | -1,258 | -1,258 | -1,258 |
| Other Investing Activity | 0 | -5,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-7,940 | $-195,645 | $-143,292 | $-122,345 | $30,038 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -143 | N/A | -535 | -393 | N/A |
| Common Stock Issued | 24,580 | 318,560 | 273,166 | 262,730 | 13,679 |
| Other Financing Activity | -10,615 | -6,269 | 96 | 84 | -232 |
| Financing Cash Flow | $13,822 | $312,291 | $272,727 | $262,421 | $13,447 |
| Beginning Cash Position | 180,527 | 46,272 | 46,272 | 46,272 | 46,272 |
| End Cash Position | 154,380 | 180,527 | 181,330 | 177,757 | 82,586 |
| Net Cash Flow | $-26,147 | $134,255 | $135,058 | $131,485 | $36,314 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,029 | 17,609 | 5,623 | -8,591 | -7,171 |
| Capital Expenditure | -11,826 | -44,571 | -30,676 | -15,663 | -6,179 |
| Free Cash Flow | -43,855 | -26,962 | -25,053 | -24,254 | -13,350 |